Literature DB >> 31620785

C3 glomerulopathy.

Jacob J E Koopman1,2, Aiko P J de Vries1, Ingeborg M Bajema3.   

Abstract

Year:  2021        PMID: 31620785     DOI: 10.1093/ndt/gfz201

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  1 in total

1.  Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial.

Authors:  Andrew S Bomback; David Kavanagh; Marina Vivarelli; Matthias Meier; Yaqin Wang; Nicholas J A Webb; Angelo J Trapani; Richard J H Smith
Journal:  Kidney Int Rep       Date:  2022-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.